FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 2025528-384.66%
Mar 31, 2024-185-86.39%
Mar 31, 2023-1,362-179.11%
Mar 31, 20221,722+239.44%
Mar 31, 2021507-160.07%
Mar 31, 2020-844-445.50%
Mar 31, 2019244+37.53%
Mar 31, 2018178-114.73%
Mar 31, 2017-1,207-1845.67%
Mar 31, 201669-74.02%
Mar 31, 2015266
AI Chat